Daiichi Sankyo Co Ltd (MEX:4568)
MXN 635.96 0 (0%) Market Cap: 1.07 Til Enterprise Value: 969.66 Bil PE Ratio: 33.70 PB Ratio: 5.15 GF Score: 68/100

Daiichi Sankyo Co Ltd ESMO 2021 Highlights Call Transcript

Sep 21, 2021 / 10:30PM GMT
Operator

Thank you for waiting. We are now ready to start Daiichi Sankyo's conference call to present ESMO 2021 highlights. Please note that today's call will be recorded under [management] of today's presentation and Q&A is English. Dr. Takeshita, please go ahead.

Ken Takeshita
Daiichi Sankyo Company, Limited - Global Head of Research & Development

Thank you very much for the introduction, and thank you to all of you for joining this call. My name is Ken Takeshita, Global Head of R&D at Daiichi Sankyo. And welcome to our conference call to present our ESMO 2021 highlights. And I'm going to follow the slide deck that you have in front of you.

Slide #2, you got your usual statement and disclaimers. So we'll go on to the Slide #3 and then 4. 3 represents our agenda for today. We'll give you the introduction, followed by highlights and actual ESMO presentation from 3 clinical trials that we would like to highlight. And then, of course, there is a very lengthy appendix we have in front of you at the end.

So Slide #4. We want to emphasize here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot